Verisante Technology Inc. V.VRS

REVENUE MODEL

[herbacious]

The Verisante AURA will require the use of a disposable end cap that must be replaced after each use for health /sanitary reasons.

thus ,in addition to revenue from initial sales of the device, the Company will also have a recurring revenue stream .

AURA sales are projected to begin in late 2011, subject to regulory approval.

INVESTEMENT HIGHLITES

REVOLUTIONARY TECHNOLOGY

IMAGING DEVICE FOR THE SAFE AND EARLY DETECTION OF SKIN CANCER

PATENT PROTECTED PLATFORM TECHNOLOGY

EXTENSIBLE TO SEVERAL OTHER FORMS OF CANCER

CLEAR REGULATORY PATHWAY THAT WILL RESULT IN SIGNIFICANT EARLY REVENUE

RECURRING REVENUE MODEL

STATEGIC ALLIANCES WITH LEADING INSTITUTIONS

WORLD CLASS SCIENTIFIC CAPABILITY

PROJECT MANAGEMENT LEAD BY EXPIENCED ,AWARD WINNING PIONEERS

MEDICAL AND TECHNICAL TEAM LEAD BY RENOWED EXPERTS

HIGHLY QUALIFIED MANAGEMENT

STRONG,INDEPENDENT BOARD


NOWS THE TIME TO GET ABOARD THIS NEW WAY OF DIAGNOSING CANCER EARLY AND WITHOUT PAIN, AND SPEED, BEFORE THE SHARE PRICE RUNS UP

do your own due diligence

herb